Key result
Trim55 mRNA levels were negatively correlated with LV mass in the F2 cross (r = -0.16, P = 0.025), identifying it as a functional candidate for spontaneous cardiac hypertrophy.
Trim55 is identified as a novel candidate gene for polygenic left ventricular hypertrophy independent of blood pressure.
New rat model decouples LV hypertrophy from BP; leaves open human genetic validation and clinical translation.
BACKGROUND: Left ventricular (LV) hypertrophy is a risk factor for cardiovascular death, but the genetic factors determining LV size and predisposition to hypertrophy are not well understood. We have previously linked the quantitative trait locus cardiac mass 22 (Cm22) on chromosome 2 with cardiac hypertrophy independent of blood pressure in the spontaneously hypertensive rat. From an original cross of spontaneously hypertensive rat with F344 rats, we derived a normotensive polygenic model of spontaneous cardiac hypertrophy, the hypertrophic heart rat (HHR) and its control strain, the normal heart rat (NHR). METHODS AND RESULTS: To identify the genes and molecular mechanisms underlying spontaneous LV hypertrophy we sequenced the HHR genome with special focus on quantitative trait locus Cm22. For correlative analyses of function, we measured global RNA transcripts in LV of neonatal HHR and NHR and 198 neonatal rats of an HHR × NHR F2 crossbred population. Only one gene within locus Cm22 was differentially expressed in the parental generation: tripartite motif-containing 55 (Trim55), with mRNA downregulation in HHR (P < 0.05) and reduced protein expression. Trim55 mRNA levels were negatively correlated with LV mass in the F2 cross (r = -0.16, P = 0.025). In exon nine of Trim55 in HHR, we found one missense mutation that functionally alters protein structure. This mutation was strongly associated with Trim55 mRNA expression in F2 rats (F = 10.35, P < 0.0001). Similarly, in humans, we found reduced Trim55 expression in hearts of subjects with idiopathic dilated cardiomyopathy. CONCLUSION: Our study suggests that the Trim55 gene, located in Cm22, is a novel candidate gene for polygenic LV hypertrophy independent of blood pressure.
No takes yet. Share an insight, caveat, or question.
Prestes et al. (2016) studied Left ventricular hypertrophy (n=198). Trim55 gene mutation and expression vs. Normal Trim55 expression / NHR strain was evaluated on Correlation of Trim55 mRNA levels with LV mass (r = -0.16, p=0.025). Trim55 mRNA levels were negatively correlated with LV mass in the F2 cross (r = -0.16, P = 0.025), identifying it as a functional candidate for spontaneous cardiac hypertrophy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: